Comprehensive Screening of Cell Surface Markers Expressed by Adult-Derived Human Liver Stem/Progenitor Cells Harvested at Passage 5: Potential Implications for Engraftment
Mesenchymal stromal cells (MSCs) are known to have potential therapeutic benefits for a number of diseases. However, many studies report low engraftment levels, regardless of the target organ. One possible explanation could be that MSCs do not express the necessary receptors for engraftment. Indeed,...
Saved in:
Main Authors: | Pierre-Edouard Dollet, Joachim Ravau, Floriane André, Mustapha Najimi, Etienne Sokal, Catherine Lombard |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2016/9302537 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cord Blood-Derived Hematopoietic Stem/Progenitor Cells: Current Challenges in Engraftment, Infection, and Ex Vivo Expansion
by: Katsuhiro Kita, et al.
Published: (2011-01-01) -
F4/80+ Host Macrophages Are a Barrier to Murine Embryonic Stem Cell-Derived Hematopoietic Progenitor Engraftment In Vivo
by: Heather L. Thompson, et al.
Published: (2016-01-01) -
Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
by: Mary Nauffal, et al.
Published: (2024-01-01) -
MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
by: Thomas J. Kean, et al.
Published: (2013-01-01) -
High-Dose Neural Stem/Progenitor Cell Transplantation Increases Engraftment and Neuronal Distribution and Promotes Functional Recovery in Rats after Acutely Severe Spinal Cord Injury
by: Taoyang Yuan, et al.
Published: (2019-01-01)